Difloxacin
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Difloxacin(F06161) |
| 2D Structure | |
| FRCD ID | F06161 |
| CAS Number | 98106-17-3 |
| PubChem CID | 56206 |
| Formula | C21H19F2N3O3 |
| IUPAC Name | 6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
| InChI Key | NOCJXYPHIIZEHN-UHFFFAOYSA-N |
| InChI | InChI=1S/C21H19F2N3O3/c1-24-6-8-25(9-7-24)19-11-18-15(10-17(19)23)20(27)16(21(28)29)12-26(18)14-4-2-13(22)3-5-14/h2-5,10-12H,6-9H2,1H3,(H,28,29) |
| Canonical SMILES | CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F |
| Isomeric SMILES | CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F |
| Synonyms |
3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo-
Difloxacin
98106-17-3
Difloxacin [INN]
6-fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
UNII-5Z7OO9FNFD
Difloxacin (INN)
C21H19F2N3O3
5Z7OO9FNFD
CHEBI:4537
|
| Classifies |
Predicted: Veterinary Drug
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Organoheterocyclic compounds |
| Class | Quinolines and derivatives |
| Subclass | Phenylquinolines |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Phenylquinolines |
| Alternative Parents |
|
| Molecular Framework | Aromatic heteropolycyclic compounds |
| Substituents | Phenylquinoline - Quinoline-3-carboxylic acid - Fluoroquinolone - N-arylpiperazine - Aminoquinoline - Haloquinoline - Dihydroquinolone - Dihydroquinoline - Pyridine carboxylic acid - Pyridine carboxylic acid or derivatives - Tertiary aliphatic/aromatic amine - Dialkylarylamine - N-alkylpiperazine - N-methylpiperazine - Fluorobenzene - Halobenzene - Benzenoid - 1,4-diazinane - Pyridine - Monocyclic benzene moiety - Piperazine - Aryl halide - Aryl fluoride - Vinylogous amide - Heteroaromatic compound - Tertiary aliphatic amine - Tertiary amine - Amino acid or derivatives - Amino acid - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Azacycle - Carboxylic acid - Hydrocarbon derivative - Organic oxygen compound - Organopnictogen compound - Organic oxide - Organohalogen compound - Organofluoride - Organonitrogen compound - Organooxygen compound - Organic nitrogen compound - Amine - Aromatic heteropolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as phenylquinolines. These are heterocyclic compounds containing a quinoline moiety substituted with a phenyl group. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 399.398 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Complexity | 672 |
| Monoisotopic Mass | 399.139 |
| Exact Mass | 399.139 |
| XLogP | 1.6 |
| Formal Charge | 0 |
| Heavy Atom Count | 29 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB- | 0.9680 |
| Human Intestinal Absorption | HIA+ | 0.9910 |
| Caco-2 Permeability | Caco2+ | 0.8792 |
| P-glycoprotein Substrate | Substrate | 0.7797 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9043 |
| Non-inhibitor | 0.9071 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6236 |
| Distribution | ||
| Subcellular localization | Lysosome | 0.4272 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8193 |
| CYP450 2D6 Substrate | Non-substrate | 0.9116 |
| CYP450 3A4 Substrate | Non-substrate | 0.6793 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8909 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9166 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9505 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8370 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9408 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7733 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8041 |
| Non-inhibitor | 0.8442 | |
| AMES Toxicity | AMES toxic | 0.8855 |
| Carcinogens | Non-carcinogens | 0.9156 |
| Fish Toxicity | High FHMT | 0.9976 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9116 |
| Honey Bee Toxicity | Low HBT | 0.9052 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.8102 |
| Carcinogenicity (Three-class) | Non-required | 0.6109 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -3.5388 | LogS |
| Caco-2 Permeability | 1.2958 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.0693 | LD50, mol/kg |
| Fish Toxicity | 1.1700 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.6603 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Cattle,Muscle | Japan | 0.4ppm | |||
| Other Aquatic Animal | Japan | 0.3ppm | |||
| Crustaceans | Japan | 0.3ppm | |||
| Shelled Molluscas | Japan | 0.3ppm | |||
| Other Fish | Japan | 0.3ppm | |||
| Salmoniformes | Japan | 0.3ppm | |||
| Anguilliformes | Japan | 0.3ppm | |||
| Perciformes | Japan | 0.3ppm | |||
| Other Poultry Animals,Edible Offal | Japan | 0.6ppm | |||
| Chicken,Edible Offal | Japan | 0.6ppm | |||
| Other Poultry Animals,Kidney | Japan | 0.6ppm | |||
| Chicken,Kidney | Japan | 0.6ppm | |||
| Other Poultry Animals,Liver | Japan | 2ppm | |||
| Chicken,Liver | Japan | 2ppm | |||
| Other Poultry Animals,Fat | Japan | 0.4ppm | |||
| Chicken,Fat | Japan | 0.4ppm | |||
| Other Poultry Animals,Muscle | Japan | 0.3ppm | |||
| Chicken,Muscle | Japan | 0.3ppm | |||
| Other Terrestrial Mammals,Edible Offal | Japan | 0.8ppm | |||
| Pig,Edible Offal | Japan | 0.02ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Efficient Reduction of Antibacterial Activity and Cytotoxicity of Fluoroquinolones by Fungal-Mediated N-Oxidation. | J Agric Food Chem | 2017 Apr 19 | 28365994 |
| Effect of various storage conditions on the stability of quinolones in raw milk. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2016Jul | 27258809 |
| Electrical field assisted matrix solid phase dispersion as a powerful tool toimprove the extraction efficiency and clean-up of fluoroquinolones in bovinemilk. | J Chromatogr A | 2016 Aug 26 | 27492598 |
| Antibiotic susceptibility profiles of Mycoplasma sp. 1220 strains isolated fromgeese in Hungary. | BMC Vet Res | 2016 Aug 19 | 27543140 |
| Evaluation and validation of a multi-residue method based on biochip technologyfor the simultaneous screening of six families of antibiotics in muscle andaquaculture products. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2016 | 26612266 |
| Determination of selected veterinary antimicrobials in poultry excreta byUHPLC-MS/MS, for application in Salmonella control programs. | Anal Bioanal Chem | 2015 Jun | 25633214 |
| Determination of fluoroquinolones in chicken feces - a new liquid-liquidextraction method combined with LC-MS/MS. | Environ Toxicol Pharmacol | 2014 Nov | 25305740 |
| Comparison of different solid-phase extraction materials for the determination offluoroquinolones in chicken plasma by LC-MS/MS. | J Chromatogr B Analyt Technol Biomed Life Sci | 2014 Mar 1 | 24566266 |
| Identification of metabolites and thermal transformation products of quinolonesin raw cow's milk by liquid chromatography coupled to high-resolution massspectrometry. | J Agric Food Chem | 2014 Feb 26 | 24499328 |
| Novel in vitro systems for prediction of veterinary drug residues in ovine milkand dairy products. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2014 | 24679113 |
| Chemiluminescence competitive indirect enzyme immunoassay for 20 fluoroquinolone residues in fish and shrimp based on a single-chain variable fragment. | Anal Bioanal Chem | 2013 Sep | 23842902 |
| Broilers as a source of quinolone-resistant and extraintestinal pathogenic Escherichia coli in the Czech Republic. | Microb Drug Resist | 2013 Feb | 23020862 |
| Analysis of quinolone antibiotics in eggs: preparation and characterization of a raw material for method validation and quality control. | Food Chem | 2012 Oct 1 | 25005999 |
| Determination of (fluoro)quinolones in eggs by liquid chromatography withfluorescence detection and confirmation by liquid chromatography-tandem massspectrometry. | Food Chem | 2012 Nov 15 | 22868110 |
| Determination of quinolones in milk samples using a combination of magneticsolid-phase extraction and capillary electrophoresis. | Electrophoresis | 2012 Jul | 22806471 |
| A sensitive chromatographic strip test for the rapid detection of enrofloxacin inchicken muscle. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2012 | 22243423 |
| Rapid screening method for quinolone residues in livestock and fishery productsusing immobilised metal chelate affinity chromatographic clean-up and liquidchromatography-fluorescence detection. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2011Sep | 21749230 |
| Determination of quinolone residues in infant and young children powdered milkcombining solid-phase extraction and ultra-performance liquidchromatography-tandem mass spectrometry. | J Chromatogr A | 2011 Oct 21 | 21683365 |
| Simple, stable and sensitive electrogenerated chemiluminescence detector forhigh-performance liquid chromatography and its application in directdetermination of multiple fluoroquinolone residues in milk. | Talanta | 2011 May 15 | 21482269 |
| Development of a quantitative multiclass/multiresidue method for 21 veterinarydrugs in shrimp. | J AOAC Int | 2011 Mar-Apr | 21563672 |